Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER

(PFE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at USD 43.65.
  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
PFIZER-1.33%233 072
JOHNSON & JOHNSON8.66%348 981
ROCHE HOLDING LTD.14.63%227 848
NOVARTIS22.44%220 893
MERCK AND COMPANY10.57%206 641
ELI LILLY AND COMPANY-0.92%113 364
ABBVIE-15.82%111 910
AMGEN-6.71%105 129
SANOFI2.93%103 743
ASTRAZENECA9.82%98 485
GLAXOSMITHKLINE7.63%97 904
NOVO NORDISK AS16.38%91 011
BRISTOL-MYERS SQUIBB COMPAN..-8.06%75 440
CELGENE CORPORATION51.58%66 725
BAYER AG-9.13%56 539
TAKEDA PHARMACEUTICAL CO LT..5.61%51 782
More Results
Financials ($)
Sales 2019 53 351 M
EBIT 2019 19 750 M
Net income 2019 13 323 M
Debt 2019 26 335 M
Yield 2019 3,34%
P/E ratio 2019 17,84
P/E ratio 2020 16,29
EV / Sales 2019 4,97x
EV / Sales 2020 4,87x
Capitalization 239 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes